A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...
Oct. 15, 2024 — Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping tools. According to researchers who discovered this new ...
Treatment options like medications or therapy ... particularly those in the severe stages, experience dementia-related psychosis. This often includes hallucinations, which can be distressing ...